Laboratory Corp of America Holdings (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 532,300 | 1,518,700 | 536,800 | 320,600 | 1,472,700 |
| Receivables | 2,260,700 | 2,097,000 | 2,098,700 | 1,997,300 | 2,978,300 |
| Inventories | 534,700 | 493,200 | 474,600 | 470,600 | 401,400 |
| Other current assets | 0 | 0 | 0 | 1,226,100 | 0 |
| TOTAL | $4,020,500 | $4,806,500 | $3,765,400 | $4,625,000 | $5,330,500 |
| Non-Current Assets | |||||
| PPE Net | 3,081,500 | 3,045,400 | 2,911,800 | 2,794,100 | 2,815,400 |
| Investments And Advances | 153,900 | 16,300 | 26,900 | 65,700 | 60,900 |
| Intangibles | 10,385,500 | 9,858,600 | 9,484,500 | 9,247,300 | 11,694,400 |
| Other Non-Current Assets | 751,300 | 652,200 | 536,500 | 3,423,000 | 484,200 |
| TOTAL | $14,372,200 | $13,572,500 | $12,959,700 | $15,530,100 | $15,054,900 |
| Total Assets | $18,392,700 | $18,379,000 | $16,725,100 | $20,155,100 | $20,385,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 840,800 | 875,800 | 827,500 | 852,200 | 621,300 |
| Accrued Expenses | 847,800 | 871,200 | 804,000 | 787,000 | 1,404,100 |
| TOTAL | $2,823,500 | $3,330,200 | $3,225,200 | $3,078,500 | $2,782,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,084,600 | 5,331,200 | 4,054,700 | 5,038,800 | 5,416,500 |
| Deferred Revenues | 439,100 | 392,200 | 421,700 | 310,600 | 558,500 |
| Other Non-Current Liabilities | 1,346,100 | 1,206,900 | 1,072,499 | 1,312,700 | 1,062,900 |
| TOTAL | $6,949,400 | $6,996,600 | $5,624,899 | $6,980,000 | $7,329,100 |
| Total Liabilities | $9,772,900 | $10,326,800 | $8,850,100 | $10,058,500 | $10,112,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,400 | 83,700 | 84,100 | 88,500 | 93,400 |
| Common Shares | 7,500 | 7,600 | 7,700 | 8,100 | 8,500 |
| Retained earnings | 8,639,900 | 8,303,400 | 7,888,200 | 10,581,700 | 10,456,800 |
| Other shareholders' equity | -27,600 | -261,600 | -59,300 | -493,200 | -191,900 |
| TOTAL | $8,619,800 | $8,052,200 | $7,875,000 | $10,096,600 | $10,273,400 |
| Total Liabilities And Equity | $18,392,700 | $18,379,000 | $16,725,100 | $20,155,100 | $20,385,400 |